临时与永久外周神经刺激后疼痛强度与阿片消耗:两年多中心分析
这项多中心回顾性研究分析了2014年至2022年间接受外周神经刺激(PNS)植入的126例慢性疼痛患者,评估术后24个月内疼痛强度和阿片消耗变化。结果显示全体队列植入后12个月疼痛评分显著下降(MD -3.0,95%CI -3.5至-2.4,P<0.0001),临时与永久PNS组间无显著差异(MD 0.0,95%CI -1.1至1.0,P=1.00),6和12个月阿片日消耗量无变化。
要点
- 临时与永久PNS均与植入后24个月内疼痛强度显著降低相关。
- 两组在12个月时的疼痛改善程度无显著差异。
- 6和12个月时全体队列阿片日消耗量未见变化。
核心结论
- 临时和永久PNS可能对慢性疼痛患者植入后24个月内的疼痛强度有降低作用,但阿片消耗无变化。
- 临时与永久植入患者的疼痛强度下降程度相当,提示临时PNS可能获得持久临床获益。
研究设计与样本
- 回顾性研究,纳入2014年1月1日至2022年2月24日期间在多中心企业接受PNS植入的所有患者,共126例。
主要发现
- 全体队列植入后12个月疼痛强度显著下降(MD -3.0,95%CI -3.5至-2.4,P<0.0001)。
- 临时与永久PNS队列12个月时疼痛下降无显著差异(MD 0.0,95%CI -1.1至1.0,P=1.00)。
- 全体、临时和永久队列在3、6和24个月所有次要时间点疼痛强度均显著下降。
- 全体队列植入后6和12个月阿片日消耗量无变化。
临床怎么用
- 对于慢性疼痛患者,可考虑临时或永久PNS以降低疼痛强度,但不应预期阿片消耗减少。
- 临时PNS可能提供与永久植入相当的长期疼痛获益。
局限性
- 随访丢失率较高,需进一步大规模研究以巩固关于PNS疗效的结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Peripheral nerve stimulation (PNS) is an emerging neuromodulation modality, yet there remains limited data highlighting its long-term effectiveness. The objective of this study was to report real-world data on pain intensity and opioid consumption after temporary and permanent PNS for chronic pain up to 24 months postimplantation. METHODS: A retrospective study was conducted on all patients who received PNS implants at a multi-centered enterprise between January 1, 2014 and February 24, 2022. The two co-primary outcomes were: (1) change in pain intensity (11-point Numerical Rating Scale) from baseline to 12 months postimplant; and (2) comparison of the change in pain intensity between temporary and permanent PNS cohorts 12 months postimplant. RESULTS: 126 patients were included in this analysis. Pain intensity significantly decreased 12 months postimplant in the overall cohort (mean difference (MD) -3.0 (95% CI -3.5 to -2.4), p<0.0001). No significant difference in this reduction was identified between temporary and permanent PNS cohorts (MD 0.0 (95% CI -1.1 to 1.0), p=1.00) 12 months postimplantation. Pain intensity significantly decreased in the overall, temporary, and permanent cohorts at all secondary time points (3, 6, and 24 months). No change in daily opioid consumption was observed at 6 and 12 months postimplant in the overall cohort. CONCLUSION: This study found that both temporary and permanent PNS may be effective for reducing pain intensity in patients with chronic pain up to 24 months postimplantation, although no changes in opioid consumption were observed. The decrease in pain intensity was comparable between patients receiving temporary versus permanent implants, highlighting that temporary PNS may achieve long-lasting clinical benefits. However, given the substantial loss to follow-up, further large-scale studies are needed to solidify conclusions about the efficacy of PNS.
引用
- West T, Hussain N, Bhatia A, et al. Pain intensity and opioid consumption after temporary and permanent peripheral nerve stimulation: a 2-year multicenter analysis. Reg Anesth Pain Med. 2025. PMID: 39060006. doi:10.1136/rapm-2024-105704
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。